SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-22-120487
Filing Date
2022-11-21
Accepted
2022-11-21 07:01:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2230974d1_424b3.htm 424B3 8356
2 GRAPHIC tm2230974d1_424b3img001.jpg GRAPHIC 27824
  Complete submission text file 0001104659-22-120487.txt   47945
Mailing Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105
Business Address 1371 EAST 2100 SOUTH SUITE 200 SALT LAKE CITY UT 84105 (781) 788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-264641 | Film No.: 221403463
SIC: 2834 Pharmaceutical Preparations